• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找多发性硬化症疲劳的脑脊液生物标志物:一项蛋白质组学研究。

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.

机构信息

Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland.

出版信息

J Sleep Res. 2019 Jun;28(3):e12721. doi: 10.1111/jsr.12721. Epub 2018 Jul 1.

DOI:10.1111/jsr.12721
PMID:29961995
Abstract

Fatigue in multiple sclerosis is a very common and cumbersome symptom, but its aetiology is poorly understood. Proteomics is increasingly implemented in multiple sclerosis research, but has not yet been used to study the neurobiological basis of fatigue in multiple sclerosis. To identify potential cerebrospinal fluid biomarkers of fatigue in multiple sclerosis, we collected cerebrospinal fluid of 20 patients with multiple sclerosis with fatigue (MS+), 20 patients with multiple sclerosis without fatigue (MS-), and 20 control subjects without multiple sclerosis and without fatigue (HC). We used a shotgun proteomics approach and label-free quantitative proteomics to analyse the protein content in cerebrospinal fluid. Selected proteins with differential abundance were further validated by immunoblotting. Out of 591 detected cerebrospinal fluid proteins, the abundance of nine proteins differed between the three groups, and seven additional proteins differed between MS+ and MS- patients. Using immunoblot or slot-blot techniques, we confirmed decreased levels of protein kinase C-binding protein NELL2, neural cell adhesion molecule L1-like protein, and reelin in MS+ patients. In conclusion, cerebrospinal fluid proteomics may provide insight into the neurobiological basis of fatigue in multiple sclerosis. The proteins identified to be decreased in MS+ are involved in synaptic plasticity and energy homeostasis, and thus appear as plausible biomarkers of this common symptom.

摘要

多发性硬化症中的疲劳是一种非常常见且令人困扰的症状,但它的病因尚未被充分理解。蛋白质组学在多发性硬化症研究中得到了越来越多的应用,但尚未用于研究多发性硬化症疲劳的神经生物学基础。为了确定多发性硬化症疲劳的潜在脑脊液生物标志物,我们收集了 20 例伴有疲劳的多发性硬化症患者(MS+)、20 例不伴有疲劳的多发性硬化症患者(MS-)和 20 例无多发性硬化症且不伴有疲劳的对照受试者(HC)的脑脊液。我们使用 shotgun 蛋白质组学方法和无标记定量蛋白质组学分析脑脊液中的蛋白质含量。通过免疫印迹进一步验证具有差异丰度的选定蛋白质。在检测到的 591 种脑脊液蛋白质中,有 9 种蛋白质在三组之间的丰度存在差异,另外 7 种蛋白质在 MS+和 MS-患者之间存在差异。使用免疫印迹或狭缝印迹技术,我们证实了 MS+患者中蛋白激酶 C 结合蛋白 NELL2、神经细胞黏附分子 L1 样蛋白和 reelin 的水平降低。总之,脑脊液蛋白质组学可能为多发性硬化症疲劳的神经生物学基础提供深入了解。在 MS+中发现减少的蛋白质参与突触可塑性和能量稳态,因此它们似乎是这种常见症状的合理生物标志物。

相似文献

1
In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.寻找多发性硬化症疲劳的脑脊液生物标志物:一项蛋白质组学研究。
J Sleep Res. 2019 Jun;28(3):e12721. doi: 10.1111/jsr.12721. Epub 2018 Jul 1.
2
Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.脑脊液的无标记液相色谱-串联质谱蛋白质组学分析确定了肌萎缩侧索硬化症的蛋白质/信号通路改变及候选生物标志物
J Proteome Res. 2015 Nov 6;14(11):4486-501. doi: 10.1021/acs.jproteome.5b00804. Epub 2015 Oct 8.
3
A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.一种用于检测神经系统疾病中脑脊液反应性的新型非偏 proteomic 方法。
Mol Cell Proteomics. 2011 Jun;10(6):M110.000042. doi: 10.1074/mcp.M110.000042. Epub 2011 Mar 18.
4
Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis.定量蛋白质组学研究表明,在多发性硬化症的病程中,分泌粒蛋白-1的脑脊液水平会降低。
Proteomics. 2015 Oct;15(19):3361-9. doi: 10.1002/pmic.201400142. Epub 2015 Sep 8.
5
Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.针对多种归一化策略的人脑脊液无标记分析,揭示受多发性硬化症影响的蛋白质组。
Proteomics. 2016 Apr;16(7):1154-65. doi: 10.1002/pmic.201500284.
6
Proteomics-based technologies in the discovery of biomarkers for multiple sclerosis in the cerebrospinal fluid.基于蛋白质组学的技术在脑脊液中多发性硬化症生物标志物的发现。
Curr Mol Med. 2011 Jun;11(4):326-49. doi: 10.2174/156652411795677981.
7
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.脑脊液几丁质酶 3 样蛋白 1 水平与多发性硬化症的转化相关。
Brain. 2010 Apr;133(Pt 4):1082-93. doi: 10.1093/brain/awq035. Epub 2010 Mar 17.
8
Cerebrospinal fluid proteomics in multiple sclerosis.多发性硬化症中的脑脊液蛋白质组学
Biochim Biophys Acta. 2015 Jul;1854(7):746-56. doi: 10.1016/j.bbapap.2014.12.013. Epub 2014 Dec 16.
9
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.多发性硬化症:新型 CSF 生物标志物的鉴定和临床评估。
J Proteomics. 2010 Apr 18;73(6):1117-32. doi: 10.1016/j.jprot.2010.01.004. Epub 2010 Jan 20.
10
Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).脑脊液蛋白质组资源(CSF-PR)的基本特征及应用案例
Methods Mol Biol. 2019;2044:377-391. doi: 10.1007/978-1-4939-9706-0_25.

引用本文的文献

1
Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis.分子模拟与HLA多态性可能驱动BNT-162b2 mRNA疫苗接种者的自身免疫:一项计算分析。
Microorganisms. 2023 Jun 28;11(7):1686. doi: 10.3390/microorganisms11071686.
2
Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.蛋白质组学方法解析多发性硬化症患者发病机制中的作用机制。
Proteomics. 2019 Aug;19(16):e1800335. doi: 10.1002/pmic.201800335. Epub 2019 Jun 21.